Literature DB >> 15372137

Memory-related hippocampal dysfunction in poly-drug ecstasy (3,4-methylenedioxymethamphetamine) users.

Jörg Daumann1, Thomas Fischermann, Karsten Heekeren, Katharina Henke, Armin Thron, Euphrosyne Gouzoulis-Mayfrank.   

Abstract

RATIONALE: 3,4-Methylenedioxymethamphetamine (MDMA, ecstasy) is neurotoxic in animal studies and its use has been associated with cognitive impairments in humans.
OBJECTIVE: To study hippocampal activation during the retrieval from episodic memory in polyvalent users of ecstasy.
METHODS: Twelve polyvalent ecstasy users and twelve matched controls were examined by means of functional magnetic resonance imaging (fMRI) while they retrieved face-profession associations from episodic memory.
RESULTS: Ecstasy users had a normal structural MRI scan without focal brain lesions or anatomical abnormalities. They exhibited equal retrieval accuracy during memory retrieval to that of the matched controls. Yet, their retrieval-related activity was lower and more spatially restricted in the left anterior hippocampus than that of the controls.
CONCLUSIONS: These results provide evidence for abnormal hippocampal functioning in MDMA users even at the presence of normal memory performance. This finding may be linked to MDMA-induced neurotoxicity and suggests that diminished hippocampal activation during memory retrieval might be a more sensitive or earlier index of MDMA-related neurotoxicity than neuropsychological performance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15372137     DOI: 10.1007/s00213-004-2002-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  40 in total

Review 1.  Role of serotonin in memory impairment.

Authors:  M C Buhot; S Martin; L Segu
Journal:  Ann Med       Date:  2000-04       Impact factor: 4.709

2.  Cognitive performance and serotonergic function in users of ecstasy.

Authors:  R J Verkes; H J Gijsman; M S Pieters; R C Schoemaker; S de Visser; M Kuijpers; E J Pennings; D de Bruin; G Van de Wijngaart; J M Van Gerven; A F Cohen
Journal:  Psychopharmacology (Berl)       Date:  2001-01-01       Impact factor: 4.530

Review 3.  Serotonin and hippocampal neurogenesis.

Authors:  E Gould
Journal:  Neuropsychopharmacology       Date:  1999-08       Impact factor: 7.853

4.  Cerebral activation in abstinent ecstasy (MDMA) users during a working memory task: a functional magnetic resonance imaging (fMRI) study.

Authors:  Jörg Daumann; Bruno Fimm; Klaus Willmes; Armin Thron; Euphrosyne Gouzoulis-Mayfrank
Journal:  Brain Res Cogn Brain Res       Date:  2003-05

5.  Brain regions associated with episodic retrieval in normal aging and Alzheimer's disease.

Authors:  L Bäckman; J L Andersson; L Nyberg; B Winblad; A Nordberg; O Almkvist
Journal:  Neurology       Date:  1999-06-10       Impact factor: 9.910

Review 6.  (+/-)3,4-Methylenedioxymethamphetamine ('Ecstasy')-induced serotonin neurotoxicity: studies in animals.

Authors:  G A Ricaurte; J Yuan; U D McCann
Journal:  Neuropsychobiology       Date:  2000       Impact factor: 2.328

7.  Positron emission tomographic evidence of toxic effect of MDMA ("Ecstasy") on brain serotonin neurons in human beings.

Authors:  U D McCann; Z Szabo; U Scheffel; R F Dannals; G A Ricaurte
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

8.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance.

Authors:  A C Parrott; J Lasky
Journal:  Psychopharmacology (Berl)       Date:  1998-10       Impact factor: 4.530

9.  Attentional processes in abstinent methylenedioxymethamphetamine (ecstasy) users.

Authors:  Konstantine K Zakzanis; Donald A Young; Nasim F Radkhoshnoud
Journal:  Appl Neuropsychol       Date:  2002

10.  Reduced cortical gray matter density in human MDMA (Ecstasy) users: a voxel-based morphometry study.

Authors:  Ronald L Cowan; In Kyoon Lyoo; Seung Mo Sung; Kyung Heup Ahn; Minue J Kim; Jaeuk Hwang; Erika Haga; Ram Lakhan Panday Vimal; Scott E Lukas; Perry F Renshaw
Journal:  Drug Alcohol Depend       Date:  2003-12-11       Impact factor: 4.492

View more
  24 in total

1.  Altered parahippocampal functioning in cannabis users is related to the frequency of use.

Authors:  Benjamin Becker; Daniel Wagner; Euphrosyne Gouzoulis-Mayfrank; Elmar Spuentrup; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2010-03-19       Impact factor: 4.530

2.  MDMA administration during adolescence exacerbates MPTP-induced cognitive impairment and neuroinflammation in the hippocampus and prefrontal cortex.

Authors:  Giulia Costa; Nicola Simola; Micaela Morelli
Journal:  Psychopharmacology (Berl)       Date:  2014-04-01       Impact factor: 4.530

3.  The Netherlands XTC Toxicity (NeXT) study: objectives and methods of a study investigating causality, course, and clinical relevance.

Authors:  Maartje M L De Win; Gerry Jager; Hylke K E Vervaeke; Thelma Schilt; Liesbeth Reneman; Jan Booij; Frank C Verhulst; Gerard J Den Heeten; Nick F Ramsey; Dirk J Korf; Wim Van den Brink
Journal:  Int J Methods Psychiatr Res       Date:  2005       Impact factor: 4.035

4.  Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study.

Authors:  John Karageorgiou; Mary S Dietrich; Evonne J Charboneau; Neil D Woodward; Jennifer U Blackford; Ronald M Salomon; Ronald L Cowan
Journal:  Neuroimage       Date:  2009-03-02       Impact factor: 6.556

Review 5.  A review of the stereotype threat literature and its application in a neurological population.

Authors:  Karen A Kit; Holly A Tuokko; Catherine A Mateer
Journal:  Neuropsychol Rev       Date:  2008-04-16       Impact factor: 7.444

6.  Decision-making in polydrug amphetamine-type stimulant users: an fMRI study.

Authors:  Philip Koester; Kirsten G Volz; Marc Tittgemeyer; Daniel Wagner; Benjamin Becker; Euphrosyne Gouzoulis-Mayfrank; Joerg Daumann
Journal:  Neuropsychopharmacology       Date:  2013-02-07       Impact factor: 7.853

7.  Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain.

Authors:  María Izco; Laura Orio; Esther O'Shea; M Isabel Colado
Journal:  Psychopharmacology (Berl)       Date:  2006-10-18       Impact factor: 4.530

8.  Incidental use of ecstasy: no evidence for harmful effects on cognitive brain function in a prospective fMRI study.

Authors:  Gerry Jager; Maartje M de Win; Hylke K Vervaeke; Thelma Schilt; Rene S Kahn; Wim van den Brink; Jan M van Ree; Nick F Ramsey
Journal:  Psychopharmacology (Berl)       Date:  2007-05-03       Impact factor: 4.530

9.  Synthetic studies and pharmacological evaluations on the MDMA ('Ecstasy') antagonist nantenine.

Authors:  Onica Legendre; Stevan Pecic; Sandeep Chaudhary; Sarah M Zimmerman; William E Fantegrossi; Wayne W Harding
Journal:  Bioorg Med Chem Lett       Date:  2009-11-20       Impact factor: 2.823

10.  Memory-related hippocampal functioning in ecstasy and amphetamine users: a prospective fMRI study.

Authors:  Benjamin Becker; Daniel Wagner; Philip Koester; Katja Bender; Christoph Kabbasch; Euphrosyne Gouzoulis-Mayfrank; Jörg Daumann
Journal:  Psychopharmacology (Berl)       Date:  2012-09-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.